FCG Investment Co Takes Position in Oscar Health, Inc. (NYSE:OSCR)

FCG Investment Co bought a new stake in Oscar Health, Inc. (NYSE:OSCR - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 46,505 shares of the company's stock, valued at approximately $986,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in OSCR. Avalon Trust Co bought a new stake in shares of Oscar Health in the 1st quarter valued at approximately $69,000. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the second quarter valued at about $78,000. Quest Partners LLC bought a new position in Oscar Health in the second quarter worth $93,000. Amalgamated Bank boosted its position in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company's stock valued at $106,000 after acquiring an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors bought a new stake in shares of Oscar Health in the 3rd quarter valued at approximately $142,000. Institutional investors own 75.70% of the company's stock.

Insider Buying and Selling

In other news, insider Mario Schlosser sold 3,198 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Alessandrea C. Quane sold 16,793 shares of the business's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now directly owns 392,607 shares in the company, valued at approximately $6,697,875.42. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock worth $3,007,069 over the last ninety days. 25.11% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

OSCR has been the topic of several research analyst reports. Piper Sandler restated an "overweight" rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group initiated coverage on Oscar Health in a report on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Oscar Health has an average rating of "Moderate Buy" and an average price target of $24.00.

Oscar Health Price Performance

Shares of NYSE:OSCR traded down $0.84 during mid-day trading on Monday, hitting $15.35. The company had a trading volume of 3,258,187 shares, compared to its average volume of 3,207,431. The firm has a fifty day moving average price of $18.80 and a 200 day moving average price of $18.37. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.91. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. During the same period in the prior year, the company posted ($0.07) earnings per share. Oscar Health's quarterly revenue was up 44.6% on a year-over-year basis. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.